ERBB4 and obesity disorder: To further confirm whether ErbB4 mediated the anti‐obesity effects of central Nrg4, HFD‐fed mice received i.c.v. administration of an ErbB4 antagonist, AG‐1478, followed by central injection of rNrg4.